History of diabetes is associated with reduced likelihoods of achieving PASI75 and PASI90 at 12-months among psoriasis patients treated with biologics: Supplemental Data
Published: 18 August 2023| Version 1 | DOI: 10.17632/pnchbrkxdz.1
Contributors:
Clinton Enos, Abby Van Voorhees, Yolanda Maldonado, Hyung-Joo Kang, Robert McLeanDescription
This data is supplement to: History of diabetes is associated with reduced likelihoods of achieving PASI75 and PASI90 at 12-months among psoriasis patients treated with biologics: A prospective analysis in the CorEvitas Psoriasis Registry This data describes the characteristics of biologic initiators within the CorEvitas Psoriasis Registry during the study period. The data is stratified by diabetes status in Table 1 and by initiated biologic class in Table 2.
Files
Categories
Dermatology, Biologic Therapy, Psoriasis